MedPath

Clinical observation of artificial tears combined with Tuina in the treatment of dry eye disease

Phase 1
Conditions
dry eye disease
Registration Number
ITMCTR2024000001
Lead Sponsor
Jiangsu Haibin Sanatorium
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

The inclusion criteria are as follows: (1) Patients aged 18-80 years, male or female. (2) Meet the diagnostic criteria for DED. (3) Have not participated in any other drug clinical trials in the past 3 months. (4) Informed about this study and signed an informed consent form, voluntarily participating in this clinical trial research.

Exclusion Criteria

The exclusion criteria are as follows: (1) patients with serious systemic diseases such as heart, brain, liver, kidney and blood system. (2) patients with Sjogren's syndrome; (3) patients with congenital organ dysfunction. (4) Lacrimal gland obstruction caused by ocular surface injury. (5) Severe meibomian gland dysfunction and other active eye diseases affected clinical observers. (6) wearing contact lenses for a long time. (7) patients with recent eye surgery. (8) Use of systemic antihistamines, anticholinergic drugs, or other hormones that interfere with the efficacy in the past 3 months; (9) patients with sensitive constitution who could not tolerate the drugs used in this study. (10) patients who could not adhere to the treatment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ocular surface disease index;
Secondary Outcome Measures
NameTimeMethod
Fluorescein break up time;Schirmer I test;Quality of life;Corneal fluorescein staining;Overall recovery;Assessment of ocular pain;
Âİ Copyright 2025. All Rights Reserved by MedPath